These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 39136792)
1. Changes in epidermal thickness and their correlation with clinical characteristics in patients with vitiligo. Huang L; Sun W; Ye Z; Liu Y; He K; Li S Arch Dermatol Res; 2024 Aug; 316(8):519. PubMed ID: 39136792 [TBL] [Abstract][Full Text] [Related]
2. Changes of epidermal thickness in vitiligo. Jung SE; Kang HY; Lee ES; Kim YC Am J Dermatopathol; 2015 Apr; 37(4):289-92. PubMed ID: 25072687 [TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of tenascin-C in vitiligo. Abdou AG; Maraee AH; Shoeib MA; Elbana R Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383 [TBL] [Abstract][Full Text] [Related]
4. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531 [TBL] [Abstract][Full Text] [Related]
5. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. Lee AY; Kim NH; Choi WI; Youm YH J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039 [TBL] [Abstract][Full Text] [Related]
6. Photoprotection in vitiligo and normal skin. A quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation. Gniadecka M; Wulf HC; Mortensen NN; Poulsen T Acta Derm Venereol; 1996 Nov; 76(6):429-32. PubMed ID: 8982403 [TBL] [Abstract][Full Text] [Related]
7. Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo. Singh A; Gotherwal V; Junni P; Vijayan V; Tiwari M; Ganju P; Kumar A; Sharma P; Fatima T; Gupta A; Holla A; Kar HK; Khanna S; Thukral L; Malik G; Natarajan K; Gadgil CJ; Lahesmaa R; Natarajan VT; Rani R; Gokhale RS Sci Rep; 2017 Aug; 7(1):9860. PubMed ID: 28852211 [TBL] [Abstract][Full Text] [Related]
8. Melanocytes are not absent in lesional skin of long duration vitiligo. Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216 [TBL] [Abstract][Full Text] [Related]
9. Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. Bondanza S; Maurelli R; Paterna P; Migliore E; Giacomo FD; Primavera G; Paionni E; Dellambra E; Guerra L Pigment Cell Res; 2007 Aug; 20(4):288-300. PubMed ID: 17630962 [TBL] [Abstract][Full Text] [Related]
10. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo. Zailaie MZ Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153 [TBL] [Abstract][Full Text] [Related]
11. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival. Kim NH; Lee AY Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556 [TBL] [Abstract][Full Text] [Related]
12. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Cario-André M; Pain C; Gauthier Y; Taïeb A Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512 [TBL] [Abstract][Full Text] [Related]
13. Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis. Elsherif R; Mahmoud WA; Mohamed RR Ultrastruct Pathol; 2022 Mar; 46(2):217-235. PubMed ID: 35243959 [TBL] [Abstract][Full Text] [Related]
14. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study. Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912 [TBL] [Abstract][Full Text] [Related]
15. Lesional skin in vitiligo exhibits delayed in vivo reepithelialization compared to the nonlesional skin. Gupta A; Chauhan A; Priya A; Mantri B; Wadhokar M; Dalave K; Shah B; Gokhale RS; Batra VV; Singh A Wound Repair Regen; 2020 May; 28(3):307-314. PubMed ID: 32003499 [TBL] [Abstract][Full Text] [Related]
16. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999 [TBL] [Abstract][Full Text] [Related]
17. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357 [TBL] [Abstract][Full Text] [Related]
19. Vitiligo. Le Poole C; Boissy RE Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of AQP-3 in vitiligo: a new potential guide for disease activity. Hodeib A; Hegab D; Rizk O; Mohammed S G Ital Dermatol Venereol; 2017 Aug; 152(4):348-354. PubMed ID: 26923934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]